Our results using the Ccr2−/− mice differ from those published by Bromley et al., who showed that the Ccr2−/− mice developed enhanced inflammation with novel features of atopic dermatitis after intradermal injections of IL-23 (ref. 51). This evidence concerns the gene IL23A and atopic eczema.